708
Views
317
CrossRef citations to date
0
Altmetric
Review

Chitosan nanoparticles for oral drug and gene delivery

&
Pages 117-128 | Published online: 09 Oct 2022

References

  • AllemannELerouxJ-CGurnyRPolymeric nano- and microparticles for the oral delivery of peptides and peptidomimeticsAdv Drug Deliv Rev1998341718910837677
  • ArturssonPLindmarkTDavisSSEffect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)Pharm Res1994111358617816770
  • BaconAMakinJSizerPJCarbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigensInfect Immun20006857647010992483
  • BehrensIPenaAIAlonsoMJComparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transportPharm Res20021911859312240945
  • Bernkop-SchnürchAKrajicekMEMucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugatesJ Control Release199850215239685888
  • Bernkop-SchnürchAScerbe-SaikoASynthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteinsPharm Res19981526399523313
  • Bernkop-SchnürchAChitosan and its derivatives: potential excipients for peroral peptide delivery systemsInt J Pharm200019411310601680
  • Bernkop-SchnürchAKastCEGuggiDPermeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systemsJ Control Release20039395103
  • Bernkop-SchnürchAGuggiDPinterYThiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery systemJ Control Release2004941778614684281
  • Bivas-BenitaMLaloupMVersteyheSGeneration of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studiesInt J Pharm2003266172714559390
  • BowmanKSarkarRRautSOral delivery of non-viral DNA nanoparticles for hemophilia A. American Society of Gene Therapy, 8th Annual Meeting [abstract]Mol Ther200511(Suppl 1) Abs 779
  • ChellatFGrandjean-LaquerriereALe NaourRMetalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticlesBiomaterials2005269617015369684
  • ChenJYangWLLiGTransfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticlesWorld J Gastroenterol2004101121614695780
  • CheungCYMurthyNStaytonPSA pH-sensitive polymer that enhances cationic lipid-mediated gene transferBioconjug Chem2001129061011716680
  • ChewJLWolfowiczCBMaoHQChitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in miceVaccine2003212720912798609
  • ClarkMAJepsonMAHirstBHExploiting M cells for drug and vaccine deliveryAdv Drug Deliv Rev2001508110611489335
  • DeaconMPMcGurkSRobertsCJAtomic force microscopy of gastric mucin and chitosan mucoadhesive systemsBiochem J20003485576310839986
  • DesaiMPLabhasetwarVAmidonGLGastrointestinal uptake of biodegradable microparticles: effect of particle sizePharm Res1996131838458987081
  • DesaiMPLabhasetwarVWalterEThe mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependentPharm Res1997141568739434276
  • DhawanSSinglaAKSinhaVREvaluation of mucoadhesive properties of chitosan microspheres prepared by different methodsAAPS PharmSciTech20046717 5 article
  • DodaneVKhanMAMerwinJREffect of chitosan on epithelial permeability and structureInt J Pharm1999182213210332071
  • EldridgeJHHammondCJMeulbroekJAControlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer’s patchesJ Control Release19901120514
  • El-ShabouriMHPositively charged nanoparticles for improving the oral bioavailability of cyclosporin-AInt J Pharm2002249101812433438
  • FangNChanVMaoH-QInteractions of phospholipid bilayer with chitosan: effect of molecular weight and pHBiomacromolecules200121161811777388
  • Fernandez-UrrusunoRCalvoPRemunan-LopezCEnhancement of nasal absorption of insulin using chitosan nanoparticlesPharm Res19991615768110554100
  • GaoSChenJXuXGalactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targetingInt J Pharm2003255576812672602
  • GoldbergMGomez-OrellanaIChallenges for the oral delivery of macromoleculesNat Rev Drug Discov200322899512669028
  • HejaziRAmijiMChitosan-based gastrointestinal delivery systemsJ Control Release2003891516512711440
  • HiranoSChitin biotechnology applicationsBiotechnol Annu Rev19962237589704098
  • HuangMFongCWKhorETransfection efficiency of chitosan vectors: Effect of polymer molecular weight and degree of deacetylationJ Control Release200510639140615967533
  • JepsonMAClarkMAFosterNTargeting to intestinal M cellsJ Anat1996189507168982824
  • KafedjiiskiKHofferMWerleMImproved synthesis and in vitro characterization of chitosan–thioethylamidine conjugateBiomaterials2006271273516045983
  • KiangTWenJLimHWThe effect of the degree of chitosan deacetylation on the efficiency of gene transfectionBiomaterials200425529330115110480
  • KiangTBrightCCheungCYFormulation of chitosan-DNA nanoparticles with poly(propyl acrylic acid) enhances gene expressionBiomater Sci Polym Ed200415140521
  • KimTHParkIKNahJWGalactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrierBiomaterials20042537839215020154
  • KimTHKimSIAkaikeTSynergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexesJ Control Release20051053546615949861
  • KockischSReesGDYoungSAPolymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potentialJ Pharm Sci20039216142312884248
  • Köping-HöggårdMVårumKMIssaMImproved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomersGene Ther20041114415215269712
  • KotzéAFThanouMMLueBenHLEnhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2)J Pharm Sci19998825379950647
  • KriegAMImmune effects and mechanisms of action of CpG motifsVaccine2001196182211090712
  • LeitnerWWYingHRestifoNPDNA and RNA-based vaccines: principles, progress and prospectsVaccine2000187657710580187
  • LeongKWMaoHQTruong-LeVLDNA-polycation nanospheres as non-viral gene delivery vehiclesJ Control Release199853183939741926
  • LiuWSunSCaoZAn investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexesBiomaterials20052627051115585274
  • LueBenHLde LeeuwBJLangemeyerMWMucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivoPharm Res1996131668728956332
  • LueBenHLde LeeuwBJLangemeyerMWMucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitroJ Control Release1997451523
  • MaZLimL-YUptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticlesPharm Res20032018121914661926
  • MaZLimTMLimL-YPharmacological activity of peroral chitosan-insulin nanoparticles in diabetic ratsInt J Pharm20052932718015778065
  • MacLaughlinFCMumperRJWangJChitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid deliveryJ Control Release199856259729801449
  • MaoH-QRoyKTroung-LeVLChitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiencyJ Control Release20017039942111182210
  • MaoSShuaiXUngerFThe depolymerization of chitosan: effects on physicochemical and biological propertiesInt J Pharm2004281455415288342
  • NeutraMRPhillipsTLMayerELTransport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer’s patchCell Tissue Res1987247537463568100
  • OkoliGHortelanoGLeongKWOral delivery of plasmid DNA encoding the factor IX gene [abstract]Proceed Intl Symp Control Rel Bioact Mater200027 Abs 234
  • OtterleiMVårumKMRyanLCharacterization of binding and TNF-A-inducing ability of chitosans on monocytes: the involvement of CD14Vaccine199412825327526573
  • PanYLiYJZhaoHYBioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivoInt J Pharm20022491394712433442
  • PregoCGarciaMTorresDTransmucosal macromolecular drug deliveryJ Control Release20051011516215588901
  • RenDYiHWangWThe enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylationCarbohydr Res200534024031016109386
  • RoyKMaoHQHuangSKOral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergyNat Med199953879110202926
  • SchipperNGVårumKMArturssonPChitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cellsPharm Res1996131686928956335
  • SchipperNGOlssonSHoogstraateJAChitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancementPharm Res19971492399244151
  • SchipperNGVårumKMStenbergPChitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancementEur J Pharm Sci199983354310425384
  • SheuERothmanSGermanMThe “Gene Pill” and its therapeutic applicationsCurr Opin Mol Ther20035420714513686
  • ShibataYFosterLAMetzgerWJAlveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in miceInfect Immun1997651734419125555
  • SinglaAKChawlaMChitosan: some pharmaceutical and biological aspects- an updateJ Pharm Pharmacol20015310476711518015
  • SnymanDHammanJHKotzéAFEvaluation of the mucoadhesive properties of N-trimethyl chitosan chlorideDrug Dev Ind Pharm20032961912602493
  • TakeuchiHMatsuiYSugiharaHEffectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugsInt J Pharm20053031607016125348
  • ThanouMVerhoefJCMarbachPIntestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivoJ Pharm Sci200089951710861597
  • ThanouMVerhoefJCJungingerHEChitosan and its derivatives as intestinal absorption enhancersAdv Drug Deliv Rev200150S9110111576697
  • ThanouMVerhoefJCVerheijdenJHMIntestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigsPharm Res200118823811474787
  • van der MerweSMVerhoefJCVerheijdenJHMTrimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugsEur J Pharm Biopharm2004582253515296951
  • WangJTauchiYDeguchiYPositively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pyloriDrug Deliv200072374311195431
  • ZhangHNeauSHIn vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylationBiomaterials2001221653811374467
  • ZhangHNeauSHIn vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contentsBiomaterials2002232761612059026